218 related articles for article (PubMed ID: 30299325)
1. Endpoints in clinical trials in cancer cachexia: where to start?
Laird BJA; Balstad TR; Solheim TS
Curr Opin Support Palliat Care; 2018 Dec; 12(4):445-452. PubMed ID: 30299325
[TBL] [Abstract][Full Text] [Related]
2. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
Ramage MI; Skipworth RJE
Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
[TBL] [Abstract][Full Text] [Related]
3. Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR; Sousa MS; Yule MS; Baracos VE; McMillan DC; Arends J; Balstad TR; Bye A; Dajani O; Dolan RD; Fallon MT; Greil C; Hjermstad MJ; Jakobsen G; Maddocks M; McDonald J; Ottestad IO; Phillips I; Sayers J; Simpson MR; Vagnildhaug OM; Solheim TS; Laird BJA; Skipworth RJE;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):816-852. PubMed ID: 38738581
[TBL] [Abstract][Full Text] [Related]
4. What are the criteria for response to cachexia treatment?
Crawford J
Ann Palliat Med; 2019 Jan; 8(1):43-49. PubMed ID: 30685983
[TBL] [Abstract][Full Text] [Related]
5. Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM; Balstad TR; Ottestad I; Bye A; Greil C; Arends J; Baracos V; Brown LR; Dajani OF; Dolan RD; Fallon M; Fraser E; Grzyb A; Hjermstad MJ; Jakobsen G; Kaasa S; McDonald J; Philips I; Sayers J; Simpson MR; Sousa MS; Skipworth RJE; Laird BJA; Solheim TS;
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):513-535. PubMed ID: 38343065
[TBL] [Abstract][Full Text] [Related]
6. Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ; Jakobsen G; Arends J; Balstad TR; Brown LR; Bye A; Coats AJS; Dajani OF; Dolan RD; Fallon MT; Greil C; Grzyb A; Kaasa S; Koteng LH; May AM; McDonald J; Ottestad I; Philips I; Roeland EJ; Sayers J; Simpson MR; Skipworth RJE; Solheim TS; Sousa MS; Vagnildhaug OM; Laird BJA;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):794-815. PubMed ID: 38553255
[TBL] [Abstract][Full Text] [Related]
7. Meaningful measures in cancer cachexia: implications for practice and research.
McDonald JJ; Fallon MT; Laird BJA
Curr Opin Support Palliat Care; 2019 Dec; 13(4):323-327. PubMed ID: 31599817
[TBL] [Abstract][Full Text] [Related]
8. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.
Anderson LJ; Lee J; Mallen MC; Migula D; Liu H; Wu PC; Dash A; Garcia JM
Clin Nutr; 2021 Mar; 40(3):978-986. PubMed ID: 32713720
[TBL] [Abstract][Full Text] [Related]
10. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in cancer cachexia clinical trials.
Wheelwright SJ; Johnson CD
Curr Opin Support Palliat Care; 2015 Dec; 9(4):325-32. PubMed ID: 26509858
[TBL] [Abstract][Full Text] [Related]
12. [Hurdles in Future Clinical Trials for Cancer Cachexia].
Naito T
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1829-1834. PubMed ID: 31879397
[TBL] [Abstract][Full Text] [Related]
13. Cardiac cachexia: the mandate to increase clinician awareness.
Lena A; Ebner N; Coats AJS; Anker MS
Curr Opin Support Palliat Care; 2019 Dec; 13(4):298-304. PubMed ID: 31469664
[TBL] [Abstract][Full Text] [Related]
14. Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series.
Yule MS; Thompson J; Leesahatsawat K; Sousa MS; Anker SD; Arends J; Balstad TR; Brown LR; Bye A; Dajani O; Fallon M; Hjermstad MJ; Jakobsen G; McDonald J; McGovern J; Roeland EJ; Sayers J; Skipworth RJE; Ottestad IO; Philips I; Simpson MR; Solheim TS; Vagnildhaug OM; McMillan D; Laird BJA; Dolan RD;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):853-867. PubMed ID: 38783477
[TBL] [Abstract][Full Text] [Related]
15. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
Mantovani G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cachexia: an overview of recent developments.
von Haehling S; Anker SD
J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
[TBL] [Abstract][Full Text] [Related]
17. What's next in using CT scans to better understand cachexia?
Antoun S; Rossoni C; Lanoy E
Curr Opin Support Palliat Care; 2018 Dec; 12(4):427-433. PubMed ID: 30239385
[TBL] [Abstract][Full Text] [Related]
18. Measuring cachexia-diagnostic criteria.
Dev R
Ann Palliat Med; 2019 Jan; 8(1):24-32. PubMed ID: 30525765
[TBL] [Abstract][Full Text] [Related]
19. Endocrinopathies and cancer cachexia.
Dev R; Del Fabbro E; Dalal S
Curr Opin Support Palliat Care; 2019 Dec; 13(4):286-291. PubMed ID: 31567482
[TBL] [Abstract][Full Text] [Related]
20. Cancer cachexia therapy: a key weapon in the fight against cancer.
Coss CC; Bohl CE; Dalton JT
Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):268-73. PubMed ID: 21415732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
